Epigenetic silencing of miR-296 and miR-512 ensures hTERT dependent apoptosis protection and telomere maintenance in basal-type breast cancer cells
SUPPLEMENTARY MATERIALS Plasmids
p-Babe-hygro-hTERT pBabe-hTERT and pMKO.1-puro hTERT shRNA were purchased from Addgene (plasmids 1773 and 10688). miR-296 vector was obtained from a published miRNA-expression vector library [7] . A miR-512 mini-gene vector was generated by amplifying the genomic region if miR-512 using GC-GGATCCCCAAAGTGCTGGGATTACAG; GCGAATTC-AAGAGGCAACCAATCCAGAC. PCR products were cloned into pMESV [7] . hTERT luciferase reporter vectors were generated by PCR amplication of the hTERT 3'UTR using the following oligonucleotides: TERT-3'-UTR-Fw: GCCGCGGC CGCTGGCCACCCGCCCACAGCCAG, TERT-3'-UTR-Rv: GCCGCGGCCGCCAAAACTGAAAAAC TCATATATTCAG. NotI digested PCR products were cloned into psiCHECK2 (Promega).
Transfection of siRNA and RNA-oligonucleotides
Cells were transfected with ON-TARGETplus smartpool hTERT siRNAs (Dharmacon), ONTARGETplus non-targeting siRNA#1 (Dharmacon), hsa-miR-296-5p or has-miR-512-5p mimic siRNAs (Dharmacon), miRIDIAN microRNA hsa-miR-296-5p or hsa-miR-512-5p haripin inhibitor (Dharmacon) or miRIDIAN microRNA mimic negative control siRNA (Dharmacon), using RNAiMAX Lipofectamine (Invitrogen) at a final concentration of 30nM according to the manufacturer's suggestions.
Quantitative RT-PCR
Total RNA was prepared using TRIzol reagent (Gibco/BRL) according to the manufacturer's protocol. For miRNA analysis 10 ng of RNA were reverse transcribed using the hsa-miR-296-5p, hsa-miR-512-5p and RNU49 TaqMan™ MicroRNA Assay systems (Applied Biosystems). The stem loop real-time PCR was performed by using Taqman Fast PCR Master mix (Life Technologies), according to the manufacturer's suggestions. Quantitative miRNA expression data was analyzed using a Bio-Rad CFX96 C1000 Touch Realtime PCR Detection System. For quantitative mRNA expression analysis 500 ng of total RNA were reverse transcripted using the QuantiTect Reverse Transcription kit (QIAGEN) according to the manufacturer's suggestions. Quantitative PCR was performed using the SYBR Green Master Mix (Applied Biosystem) and analyzed with a StepOnePlus real time PCR machine (Applied Biosystem). mRNA levels were normalized to actin. PCR primers used for quantitative real-time PCR: hTERT_FW: 
Statistical analysis
Unless otherwise indicated in figure legends, statistical analysis of experiments with 3-5 replicas was performed using a non-parametric Man Whitney test. In figures with replica numbers >5 an unpaired students t-test was used. Information on statistical methods for analysis of patient data is mentioned in the respective figure legends. subtypes using the METABRIC-dataset [1] . Expression values are shown in box blots at a log2 scale; box extremes indicate first and third quartile, whiskers extend to the extreme values included in the interval calculated as +/-1.58 IQR/sqrt(n) where IQR (interquartile range) is calculated as the third quartile minus the first quartile; p-values are calculated comparing normal breast against all cancer samples expression levels (Wilcox test). (B) Sequence alignment of miR-296-5p and miR-512-5p to the hTERT 3'UTR of the indicated species. (C, D) Luciferase reporter assays using Hela cells transfected with wild-type hTERT 3'UTR luciferase reporter or the indicated hTERT 3'UTR luciferase reporters carrying mutations for miR-296-5p target sites (C) or miR-512-5p target sites (D). Mutations in the hTERT 3'UTR increase luciferase reporter activity. n, number of independent experiments; error bars show standard deviation, E-M.: p values were calculated using a Mann Whitney test. luminal type MCF7 cells, as determined by quantitative TaqMan RT-PCR. miR-296-5p and miR512-5p levels were quantified against RNU49. Expression of HMEC was set "1" (C-F) Luciferase reporter assays in Hela cells using a wild-type hTERT 3'UTR (C) or hTERT 3'UTR constructs that contain mutations of the respective miR-296-5p target sites (D-F). Mutations of miR-296-5p target sites result in increased luciferase reporter activity, when compared to control miRNA transfected cells. (G-H) Luciferase reporter assays in Hela cells using a wild-type hTERT 3'UTR (G) or a hTERT 3'UTR construct that contains a mutation of the miR-512-5p target site (H). Mutations of miR-512-5p target sites result in increased luciferase reporter activity, when compared to control miRNA transfected cells. (I) hTERT 3'UTR luciferase reporter assay after transient transfection of the indicated miRNA inhibitors in MDA-MB-231 cells. n, number of independent experiments; error bars show standard deviation, p values were calculated using a Mann Whitney test; n.s., non significant -p-value >0,05. Quantification of telomere length of cells described in (G) [4] . (H) Telomere length categories of cells analyzed by telomere DNA FISH in (F, G).; n= number of nuclei analyzed; N, number of telomeres analyzed; average telomere length is indicated by a red bar; numeric average telomere length and standard variation are indicated; a.u.f, arbitrary fluorescence units; an unpaired student's t-test was used to calculate statistical significance. (Material and methods section) . The GOBO tool was used [3] . Red line: high hTERT mRNA expression; grey line: low expression of hTERT. n, number of patients. P-value was calculated by Mantel-Haenszel test. (C) Multivariate analysis showing that low hTERT expression behaves as independent predictor of poor clinical outcome in basal type breast cancer in the GOBO dataset [4] . In the panel for each clinical variable and hTERT expression, hazard ratios and corresponding p-value, calculated by cox-regression analysis, are shown. (D-I) Kaplan-Meier survival curve of time considering both distant metastasis free survival and relapse free survival (DMSF_mixed) of the indicated breast cancer categories. The GOBO tool was used [3] . Patient samples were grouped according to hTERT (Material and methods section). Red line: high hTERT mRNA expression; grey line: low expression of hTERT. n, number of patients. P-value was calculated by Mantel-Haenszel test. HU is an intrinsic gene expression classifier consisting of a list of genes and a cell proliferation signature that defines breast subtypes [5] . . Patient samples were grouped according to the expression levels of miR-296-5p target genes that were experimentally validated (A, see panels F-H); (Material and methods). Red line: high miR-296-5p target gene expression; grey line: low miR-296-5p target gene expression. HU is a list of genes and a cell proliferation signature that divides breast cancer samples different subtypes [5] ; PAM50 is a 50-gene breast cancer subtype predictor [6] . Survival curves: n, number of patients. P-value was calculated using the Mantel-Haenszel test. Quantitative RT-PCR experiments: n, number of independent experiments; error bars show standard deviation, p values in B-E were calculated using a Mann Whitney test; n.s., non significant -p-value >0,05. low miR-512-5p target gene expression; HU is a list of genes and a cell proliferation signature that divides breast cancer samples different subtypes [5] ; PAM50 is a 50-gene breast cancer subtype predictor [6] . (L, M) miR-296-5p (L) and miR-512-5p (M) expression in human mammary epithelial cells, basal type MDA-MB-231 and luminal type MCF7 cells, as determined by quantitative TaqMan RT-PCR. miRNA levels were quantified against RNU49. ΔCt values (Ct miRNA -Ct RNU49) are indicated. Survival curves: n, number of patients. P-value was calculated using the Mantel-Haenszel test. [5] [6] [7] [8] [9] [10] [11] [12] ; RT-PCR analysis: n, number of independent experiments; error bars show standard deviation, p values in B-I were calculated using a Mann Whitney test; n.s., non significant -p-value >0,05.
